These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22426480)

  • 1. Androgen receptor is up-regulated by a BLT2-linked pathway to contribute to prostate cancer progression.
    Lee JW; Kim GY; Kim JH
    Biochem Biophys Res Commun; 2012 Apr; 420(2):428-33. PubMed ID: 22426480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BLT2 promotes the invasion and metastasis of aggressive bladder cancer cells through a reactive oxygen species-linked pathway.
    Kim EY; Seo JM; Kim C; Lee JE; Lee KM; Kim JH
    Free Radic Biol Med; 2010 Sep; 49(6):1072-81. PubMed ID: 20600831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro-survival of estrogen receptor-negative breast cancer cells is regulated by a BLT2-reactive oxygen species-linked signaling pathway.
    Choi JA; Lee JW; Kim H; Kim EY; Seo JM; Ko J; Kim JH
    Carcinogenesis; 2010 Apr; 31(4):543-51. PubMed ID: 19748928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the leukotriene B4 receptor 2-reactive oxygen species (BLT2-ROS) cascade following detachment confers anoikis resistance in prostate cancer cells.
    Lee JW; Kim JH
    J Biol Chem; 2013 Oct; 288(42):30054-30063. PubMed ID: 23986446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proinflammatory cytokine IL-1beta stimulates IL-8 synthesis in mast cells via a leukotriene B4 receptor 2-linked pathway, contributing to angiogenesis.
    Kim GY; Lee JW; Ryu HC; Wei JD; Seong CM; Kim JH
    J Immunol; 2010 Apr; 184(7):3946-54. PubMed ID: 20194723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpressed androgen receptor linked to p21WAF1 silencing may be responsible for androgen independence and resistance to apoptosis of a prostate cancer cell line.
    Wang LG; Ossowski L; Ferrari AC
    Cancer Res; 2001 Oct; 61(20):7544-51. PubMed ID: 11606392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive oxygen species are generated through a BLT2-linked cascade in Ras-transformed cells.
    Choi JA; Kim EY; Song H; Kim C; Kim JH
    Free Radic Biol Med; 2008 Feb; 44(4):624-34. PubMed ID: 18082638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ras-induced invasion and metastasis are regulated by a leukotriene B4 receptor BLT2-linked pathway.
    Kim EY; Seo JM; Cho KJ; Kim JH
    Oncogene; 2010 Feb; 29(8):1167-78. PubMed ID: 19935719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactive oxygen species mediate androgen receptor- and serum starvation-elicited downstream signaling of ADAM9 expression in human prostate cancer cells.
    Shigemura K; Sung SY; Kubo H; Arnold RS; Fujisawa M; Gotoh A; Zhau HE; Chung LW
    Prostate; 2007 May; 67(7):722-31. PubMed ID: 17342749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
    Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
    Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.
    Lee SO; Chun JY; Nadiminty N; Lou W; Gao AC
    Prostate; 2007 May; 67(7):764-73. PubMed ID: 17373716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of airway inflammation and hyperresponsiveness by inhibition of BLT2, a low-affinity leukotriene B4 receptor.
    Cho KJ; Seo JM; Shin Y; Yoo MH; Park CS; Lee SH; Chang YS; Cho SH; Kim JH
    Am J Respir Cell Mol Biol; 2010 Mar; 42(3):294-303. PubMed ID: 19448154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of prostate cancer cell survival after inhibition of AR expression.
    Cohen MB; Rokhlin OW
    J Cell Biochem; 2009 Feb; 106(3):363-71. PubMed ID: 19115258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
    Chiu FL; Lin JK
    Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer.
    Jackson KM; Frazier MC; Harris WB
    Anticancer Res; 2007; 27(3B):1483-8. PubMed ID: 17595765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells.
    Altuwaijri S; Lin HK; Chuang KH; Lin WJ; Yeh S; Hanchett LA; Rahman MM; Kang HY; Tsai MY; Zhang Y; Yang L; Chang C
    Cancer Res; 2003 Nov; 63(21):7106-12. PubMed ID: 14612503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
    Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the androgen receptor in the development and progression of prostate cancer.
    Jenster G
    Semin Oncol; 1999 Aug; 26(4):407-21. PubMed ID: 10482183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.